Co-Authors
This is a "connection" page, showing publications co-authored by Yu-Tao Xiang and Christoph Correll.
Connection Strength
0.656
-
ECT augmentation of clozapine for clozapine-resistant schizophrenia: A meta-analysis of randomized controlled trials. J Psychiatr Res. 2018 10; 105:23-32.
Score: 0.195
-
Baseline Characteristics and Early Response at Week 1 Predict Treatment Outcome in Adolescents With Bipolar Manic or Mixed Episode Treated With Olanzapine: Results From a 3-Week, Randomized, Placebo-Controlled Trial. J Clin Psychiatry. 2017 Nov/Dec; 78(9):e1158-e1166.
Score: 0.185
-
Antipsychotic augmentation vs. monotherapy in schizophrenia: systematic review, meta-analysis and meta-regression analysis. World Psychiatry. 2017 Feb; 16(1):77-89.
Score: 0.176
-
Changes in telepsychiatry regulations during the COVID-19 pandemic: 17 countries and regions' approaches to an evolving healthcare landscape. Psychol Med. 2020 Nov 27; 1-8.
Score: 0.057
-
Efficacy of Atypical Antipsychotics in the Management of Acute Agitation and Aggression in Hospitalized Patients with Schizophrenia or Bipolar Disorder: Results from a Systematic Review. Shanghai Arch Psychiatry. 2016 Oct 25; 28(5):241-252.
Score: 0.043